GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Inventories, Raw Materials & Components

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Inventories, Raw Materials & Components : HK$78 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings Inventories, Raw Materials & Components?

Zhongzhi Pharmaceutical Holdings's inventories, raw materials & components for the quarter that ended in Dec. 2023 was HK$78 Mil.

Zhongzhi Pharmaceutical Holdings's quarterly raw materials increased from Dec. 2022 (HK$63 Mil) to Jun. 2023 (HK$68 Mil) and increased from Jun. 2023 (HK$68 Mil) to Dec. 2023 (HK$78 Mil).

Zhongzhi Pharmaceutical Holdings's annual raw materials increased from Dec. 2021 (HK$56 Mil) to Dec. 2022 (HK$63 Mil) and increased from Dec. 2022 (HK$63 Mil) to Dec. 2023 (HK$78 Mil).

Zhongzhi Pharmaceutical Holdings Inventories, Raw Materials & Components Historical Data

The historical data trend for Zhongzhi Pharmaceutical Holdings's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhi Pharmaceutical Holdings Inventories, Raw Materials & Components Chart

Zhongzhi Pharmaceutical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.35 55.45 55.55 63.20 77.79

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.55 53.86 63.20 67.55 77.79

Zhongzhi Pharmaceutical Holdings Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Inventories, Raw Materials & Components
Comparable Companies
HKSE:01652 HKSE:02161 HKSE:02633 HKSE:08049 HKSE:00950 HKSE:00503 HKSE:02552 HKSE:01061 HKSE:02348 HKSE:00239 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN
Website
https://www.zeus.cn
Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations can be divided into three segments, namely Pharmaceutical manufacturing, Operation of chain pharmacies, and Operation of online pharmacies in Zhongshan in the Guangdong province, the PRC. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. The Operation of online pharmacies segment sells medicines online. It derives a majority of its revenue from the PRC.

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Headlines

No Headlines